 Dicerna Pharmaceuticals DRNA stock is surging higher on Thursday following news of a massive 3.3 billion deal with Novo Nordisk. The post DRNA Stock: The 3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today appeared first on InvestorPlace. 